In a strategic move to enhance precision in oncology drug development, Japanese pharmaceutical giant Daiichi Sankyo has announced a significant…
Read More

In a strategic move to enhance precision in oncology drug development, Japanese pharmaceutical giant Daiichi Sankyo has announced a significant…
Read More
Boston, MA & Tokyo, Japan – April 17, 2026 – In a significant move to enhance the precision and efficacy…
Read More
In a significant move poised to accelerate the innovation pipeline for antibody-drug conjugate (ADC) therapies, Japanese pharmaceutical giant Daiichi Sankyo…
Read More